Monday, September 14, 2026

Essential Guide to the 2026 Biohealth Supply Chain Stability Project: What You Need to Know

KHIDI is recruiting organizations for the 2026 Biohealth Supply Chain Stability Support Project to enhance the biohealth industry's resilience.

THE CEO CRIES FOUL: NVIDIA’s Jensen Huang Says US Is SO BLIND To China’s ‘Free Electricity’ AI Advantage

Jensen Huang warns that China may surpass the U.S. in AI due to lower energy costs and better regulations, urging optimism in the West.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

Tag: orforglipron

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.